{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:09:14Z","timestamp":1792786154509,"version":"4.5.0"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","license":[{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Talents of Scientific Research Fund Program from Yijishan Hospital Affiliated Wannan Medical School","award":["YR201918"],"award-info":[{"award-number":["YR201918"]}],"id":[{"id":"https:\/\/ror.org\/05wbpaf14","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Horizontal Research Fund of Wannan Medical College","award":["662202404013"],"award-info":[{"award-number":["662202404013"]}],"id":[{"id":"https:\/\/ror.org\/037ejjy86","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,3,6]]},"abstract":"<jats:p>\n                    Gout is a chronic inflammatory disease driven by hyperuricemia and recurrent immune activation. However, gout may occur in the absence of elevated serum uric acid levels, which complicates clinical diagnosis and highlights the need for reliable molecular biomarkers. The molecular mechanisms underlying gout progression remain incompletely understood. This observational study integrated bioinformatics analyses with experimental validation. Publicly available transcriptomic datasets were analyzed to identify differentially expressed genes between gout patients and healthy controls. Functional enrichment analysis, protein\u2013protein interaction network construction, immune cell infiltration analysis, competing endogenous RNA network analysis, and gene set enrichment analysis were performed to explore C-X-C motif chemokine ligand 8 (\n                    <jats:italic toggle=\"yes\">CXCL8<\/jats:italic>\n                    )-associated molecular pathways. In vitro experiments were conducted to evaluate hyperuricemia-induced inflammatory responses in renal cells. A total of 1848 differentially expressed genes were identified, which were predominantly enriched in immune and inflammatory regulatory pathways. Five hub genes were highlighted, among which\n                    <jats:italic toggle=\"yes\">CXCL8<\/jats:italic>\n                    emerged as a key mediator of immune cell activation. Gene set enrichment analysis revealed that\n                    <jats:italic toggle=\"yes\">CXCL8<\/jats:italic>\n                    was significantly associated with inflammatory signaling pathways, including the NOD-like receptor signaling pathway. Potential upstream regulators of\n                    <jats:italic toggle=\"yes\">CXCL8<\/jats:italic>\n                    were also identified. Experimental validation demonstrated that elevated uric acid levels induced renal cell injury and inflammatory responses, accompanied by increased\n                    <jats:italic toggle=\"yes\">CXCL8<\/jats:italic>\n                    expression and activation of the NOD-like receptor family pyrin domain containing 3 inflammasome pathway. This study preliminarily identifies\n                    <jats:italic toggle=\"yes\">CXCL8<\/jats:italic>\n                    as a critical inflammatory mediator involved in gout progression and suggests its potential value as a molecular biomarker and therapeutic target, providing a basis for future diagnostic and therapeutic strategies.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000047873","type":"journal-article","created":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T08:02:25Z","timestamp":1773043345000},"page":"e47873","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["A bioinformatics and experimental study toward new therapeutic strategies: CXCL8 in gout progression"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-1645-8229","authenticated-orcid":false,"given":"Chao","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Nephrology, Tongling Hospital of Traditional Chinese Medicine, Tongling, Anhui, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunhong","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Yijishan Hospital of Wannan Medical College, Wuhu, Anhui, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoming","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Yijishan Hospital of Wannan Medical College, Wuhu, Anhui, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Yijishan Hospital of Wannan Medical College, Wuhu, Anhui, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Yijishan Hospital of Wannan Medical College, Wuhu, Anhui, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1867-9778","authenticated-orcid":false,"given":"Yanlang","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Yijishan Hospital of Wannan Medical College, Wuhu, Anhui, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20261009","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1136\/annrheumdis-2019-215315","article-title":"2018 updated European League Against Rheumatism evidence-based recommendations for the diagnosis of gout.","volume":"79","author":"Richette","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"R2-20261009","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1016\/S2665-9913(21)00319-2","article-title":"Association between serum urate and flares in people with gout and evidence for surrogate status: a secondary analysis of two randomised controlled trials.","volume":"4","author":"Stamp","year":"2022","journal-title":"Lancet Rheumatol"},{"key":"R3-20261009","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1038\/s41588-019-0504-x","article-title":"Target genes, variants, tissues and transcriptional pathways influencing human serum urate levels.","volume":"51","author":"Tin","year":"2019","journal-title":"Nat Genet"},{"key":"R4-20261009","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1136\/annrheumdis-2017-212288","article-title":"Relationship between serum urate concentration and clinically evident incident gout: an individual participant data analysis.","volume":"77","author":"Dalbeth","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"R5-20261009","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/s13075-018-1697-6","article-title":"The risk of clinically diagnosed gout by serum urate levels: results from 30 years follow-up of the Malm\u00f6 Preventive Project cohort in southern Sweden.","volume":"20","author":"Kapetanovic","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"R6-20261009","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/S0140-6736(21)00569-9","article-title":"Gout.","volume":"397","author":"Dalbeth","year":"2021","journal-title":"Lancet"},{"key":"R7-20261009","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s41584-018-0004-x","article-title":"An update on the genetics of hyperuricaemia and gout.","volume":"14","author":"Major","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"R8-20261009","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/BOR.0000000000000028","article-title":"Definition of hyperuricemia and gouty conditions.","volume":"26","author":"Bardin","year":"2014","journal-title":"Curr Opin Rheumatol"},{"key":"R9-20261009","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1136\/annrheumdis-2013-204067","article-title":"Familial aggregation of gout and relative genetic and environmental contributions: a nationwide population study in Taiwan.","volume":"74","author":"Kuo","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"R10-20261009","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1161\/HYPERTENSIONAHA.120.16547","article-title":"Urate, blood pressure, and cardiovascular disease: evidence from mendelian randomization and meta-analysis of clinical trials.","volume":"77","author":"Gill","year":"2021","journal-title":"Hypertension"},{"key":"R11-20261009","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1093\/ndt\/gfz028","article-title":"Personalized medicine in chronic kidney disease by detection of monogenic mutations.","volume":"35","author":"Connaughton","year":"2020","journal-title":"Nephrol Dial Transplant"},{"key":"R12-20261009","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1093\/ndt\/gfy261","article-title":"Evolving role of genetic testing for the clinical management of autosomal dominant polycystic kidney disease.","volume":"34","author":"Lanktree","year":"2019","journal-title":"Nephrol Dial Transplant"},{"key":"R13-20261009","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1172\/JCI72272","article-title":"Genetic mechanisms and signaling pathways in autosomal dominant polycystic kidney disease.","volume":"124","author":"Harris","year":"2014","journal-title":"J Clin Invest"},{"key":"R14-20261009","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13059-017-1215-1","article-title":"Multi-omics approaches to disease.","volume":"18","author":"Hasin","year":"2017","journal-title":"Genome Biol"},{"key":"R15-20261009","doi-asserted-by":"crossref","first-page":"1304661","DOI":"10.3389\/fgene.2023.1304661","article-title":"Machine learning and multi-omics data in chronic lymphocytic leukemia: the future of precision medicine?","volume":"14","author":"Tsagiopoulou","year":"2023","journal-title":"Front Genet"},{"key":"R16-20261009","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/BOR.0000000000000861","article-title":"Update on gout management: what is old and what is new.","volume":"34","author":"Afinogenova","year":"2022","journal-title":"Curr Opin Rheumatol"},{"key":"R17-20261009","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41423-023-00974-6","article-title":"The chemokines CXCL8 and CXCL12: molecular and functional properties, role in disease and efforts towards pharmacological intervention.","volume":"20","author":"Cambier","year":"2023","journal-title":"Cell Mol Immunol"},{"key":"R18-20261009","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/nri.2016.49","article-title":"Neutrophil migration in infection and wound repair: going forward in reverse.","volume":"16","author":"de Oliveira","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"R19-20261009","doi-asserted-by":"crossref","first-page":"723846","DOI":"10.3389\/fmolb.2022.723846","article-title":"CXCL8 in Tumor Biology and Its Implications for Clinical Translation.","volume":"9","author":"Xiong","year":"2022","journal-title":"Front Mol Biosci"},{"key":"R20-20261009","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.7150\/thno.15625","article-title":"Role of the CXCL8-CXCR1\/2 axis in cancer and inflammatory diseases.","volume":"7","author":"Ha","year":"2017","journal-title":"Theranostics"},{"key":"R21-20261009","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/1471-2105-15-155","article-title":"A method for increasing expressivity of Gene Ontology annotations using a compositional approach.","volume":"15","author":"Huntley","year":"2014","journal-title":"BMC Bioinf"},{"key":"R22-20261009","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/nar\/28.1.27","article-title":"KEGG: kyoto encyclopedia of genes and genomes.","volume":"28","author":"Kanehisa","year":"2000","journal-title":"Nucleic Acids Res"},{"key":"R23-20261009","doi-asserted-by":"crossref","first-page":"D607","DOI":"10.1093\/nar\/gky1131","article-title":"STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets.","volume":"47","author":"Szklarczyk","year":"2019","journal-title":"Nucleic Acids Res"},{"issue":"Suppl 4","key":"R24-20261009","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1186\/1752-0509-8-S4-S11","article-title":"cytoHubba: identifying hub objects and sub-networks from complex interactome.","volume":"8","author":"Chin","year":"2014","journal-title":"BMC Syst Biol"},{"key":"R25-20261009","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/978-1-4939-7493-1_12","article-title":"Profiling tumor infiltrating immune cells with CIBERSORT.","volume":"1711","author":"Chen","year":"2018","journal-title":"Methods Mol Biol"},{"key":"R26-20261009","first-page":"81","article-title":"Further evaluation of teaching behavior technicians to input data and graph using graphpad prism.","volume":"20","author":"Mitteer","year":"2020","journal-title":"Behav Anal (Wash D C)"},{"key":"R27-20261009","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.12659\/MSM.901191","article-title":"Identification of key genes affecting results of hyperthermia in osteosarcoma based on integrative ChIP-Seq\/TargetScan analysis.","volume":"23","author":"Shi","year":"2017","journal-title":"Med Sci Monit"},{"key":"R28-20261009","doi-asserted-by":"crossref","first-page":"W244","DOI":"10.1093\/nar\/gkaa467","article-title":"miRNet 2.0: network-based visual analytics for miRNA functional analysis and systems biology.","volume":"48","author":"Chang","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"R29-20261009","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R30-20261009","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1002\/art.38747","article-title":"Contribution of mast cell-derived interleukin-1\u03b2 to uric acid crystal-induced acute arthritis in mice.","volume":"66","author":"Reber","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"R31-20261009","doi-asserted-by":"crossref","first-page":"101763","DOI":"10.1016\/j.trim.2022.101763","article-title":"Increase in different peripheral effector T subsets in acute and chronic gout.","volume":"76","author":"Zhao","year":"2022","journal-title":"Transpl Immunol"},{"key":"R32-20261009","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1038\/s41374-022-00798-4","article-title":"Distinct macrophage polarization in acute and chronic gout.","volume":"102","author":"Zhao","year":"2022","journal-title":"Lab Invest"},{"key":"R33-20261009","doi-asserted-by":"crossref","first-page":"e180984","DOI":"10.1172\/JCI180984","article-title":"Advancing chemokine research: the molecular function of CXCL8.","volume":"134","author":"Hou","year":"2024","journal-title":"J Clin Invest"},{"key":"R34-20261009","doi-asserted-by":"crossref","first-page":"1282890","DOI":"10.3389\/fimmu.2023.1282890","article-title":"The dysregulation of immune cells induced by uric acid: mechanisms of inflammation associated with hyperuricemia and its complications.","volume":"14","author":"Li","year":"2023","journal-title":"Front Immunol"},{"key":"R35-20261009","first-page":"270","article-title":"Reciprocal interaction between macrophage migration inhibitory factor and interleukin-8 in gout.","volume":"37","author":"Kim","year":"2019","journal-title":"Clin Exp Rheumatol"},{"key":"R36-20261009","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.3390\/ijms20133328","article-title":"The NLRP3 inflammasome: an overview of mechanisms of activation and regulation.","volume":"20","author":"Kelley","year":"2019","journal-title":"Int J Mol Sci"},{"key":"R37-20261009","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3389\/fphar.2015.00262","article-title":"NLRP3 inflammasome and its inhibitors: a review.","volume":"6","author":"Shao","year":"2015","journal-title":"Front Pharmacol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000047873","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T18:09:03Z","timestamp":1791569343000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000047873"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,6]]},"references-count":37,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000047873","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,6]]},"assertion":[{"value":"2025-01-09","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-10","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}